BiotechTubeBiotechTube
Home/Corvus Pharmaceuticals/William Ben Jones, Ph.D.
WB

William Ben Jones, Ph.D.

Senior Vice President, Pharmaceutical Development

Corvus Pharmaceuticals

Therapeutic Areas

OncologyImmunology

Corvus Pharmaceuticals Pipeline

DrugIndicationPhase
Soquelitinib (CPI-818)Relapsed/Refractory T Cell Lymphomas (TCL)Phase 1
Ciforadenant (CPI-444)CancerPhase 1/2
Mupadolimab (CPI-006)Non-Small Cell Lung Cancer (NSCLC)Phase 1/2

Leadership Team at Corvus Pharmaceuticals

RA
Richard A. Miller, M.D.
President, CEO, and Co-Founder
LL
Leiv Lea
Chief Financial Officer
JA
Jeffrey Arcara
Chief Business Officer
OA
Otute Akiti, Ph.D.
Vice President, CMC
GL
Gabriel Luciano
Vice President, Clinical Operations
View full Corvus Pharmaceuticals profile